21 CFR 862.3320

§ 862.3320 Digoxin test system.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 862.3320, § 862.3320 Digoxin test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89260
Permanent ID: ys:prov:89260@1
SHA-256: 2f6b3283af1cc2a3be6a6eee6e1294a208446c54f0e2c0f40a5a5280bdc10bd3

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. A digoxin test system is a device intended to measure digoxin, a cardiovascular drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure appropriate therapy. (b) Classification. Class II.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.